Liposome-blood protein interactions in relation to liposome clearance

Journal of Liposome Research

Volumn 6, Issue 1, 1996, Pages 33-60

  Semple, Sean C ^a   Chonn, Arcadio ^a  

^a Inex Pharmaceuticals Corporation   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FATTY ACID; LIPID; LIPOSOME; PLASMA PROTEIN;

ANIMAL EXPERIMENT; DRUG CLEARANCE; DRUG STABILITY; DRUG TARGETING; DRUG TRANSPORT; LIPID BILAYER; LIPID COMPOSITION; MEMBRANE VESICLE; MOUSE; NONHUMAN; PERIPHERAL CIRCULATION; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW;

EID: 0029929533     PISSN: 08982104     EISSN: None     Source Type: Journal    
DOI: 10.3109/08982109609037201     Document Type: Review

References (113)

1. Senior, J. 1987. Fate and behavior of liposomes in vivo: a review of controlling factors. Crit. Rev. Ther. Drug Carrier Syst. 3:123.
2. Senior, J. and Gregoriadis, G. 1982. Is half-life of circulating liposomes determined by changes in their permeability? FEBS Lett. 145:109.
3. Needham, D., McIntosh, T.J. and Lasic, D.D. 1992. Repulsive interactions and mechanical stability of polymer-grafted lipid membranes. Biochim. Biophys. Acta 1108(1):40.
4. Black, C. D. V. and Gregoriadis, G. 1976. Interaction of liposomes with blood plasma proteins. Biochem. Soc. Trans. 4:253.
5. Juliano, R.L. and Lin, G. 1980. The interaction of plasma proteins with liposomes: protein binding and effects on the clotting and complement systems. In "Liposomes and Immunobiology." H. Six. and B. Tom (Eds.). Elsevier, Amsterdam p. 49.
6. Bonte, F. and Juliano, R. L. 1986. Interactions of liposomes with serum proteins. Chem. Phys. Lipids 40:359.
7. Chonn, A., Semple, S.C. and Cullis, P.R. 1992. Association of blood proteins with large unilamellar liposomes in vivo: relation to circulation lifetimes. J. Biol. Chem. 267(26): 18759.
8. Abra, R.M. and Hunt, C.A. 1981. Liposome disposition in vivo. III. Dose and vesicle-size effects. Biochim. Biophys. Acta 666:493.
9. Senior, J., Crawley, J.C.W. and Gregoriadis, G. 1985. Tissue distribution of liposomes exhibiting half-lives in the circulation after in vivo injection. Biochim. Biophys. Acta 839:1.
10. Hope, M. J., Bally, M. B., Webb, G. and Cullis, P. R. 1985. Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size, trapped volume and ability to maintain a membrane potential. Biochim. Biophys. Acta. 812:55.
11. Lichtenberg, D., Freire, E., Schmidt, C.F., Barenholz, Y., Felgner, P.L. and Thompson, T.E. 1981. Effect of surface curvature on stability, thermodynamic behavior, and osmotic activity of dipalmitoylphosphatidylcholine single lamellar vesicles. Biochemistry 20:3426.
12. Wong, M., Anthony, F.H., Tillack, T.W. and Thompson, T.E. 1982. Fusion of dipalmitoylphosphatidylcholine vesicles at 4°C. Biochemistry 21:4126.
13. Parente, R. A. and Lentz, B. E. 1984. Phase behavior of large unilamellar vesicles composed of synthetic phospholipids. Biochemistry 23:2353.
14. Scherphof, G.L. and Morselt, H. 1984. On the size-dependent disintegration of small unilamellar phosphatidylcholine vesicles in rat plasma: evidence of complete loss of vesicle structure. Biochem. J. 221:423.
15. Chonn, A., Semple, S. C. and Cullis, P. R. 1991. Separation of large unilamellar liposomes from blood components by a spin column procedure: towards identifying plasma proteins which mediate liposome clearance in vivo. Biochim. Biophys. Acta. 1070:215.
16. Hernandez-Caselles, T., Villalain, J. and Gomez-Fernandez, J.C. 1993. Influence of liposome charge and composition on their interaction with human blood serum proteins. Molec. Cell. Bioc. 120:119.
17. Senior, J., Trimble, K.R. and Maskiewicz, R. 1991. Interaction of positively-charged liposomes with blood: implications for their application in vivo. Biochim. Biophys. Acta 1070:173.
18. Chonn, A., Semple, S.C. and Cullis, P.R. 1994. Protein-membrane interactions in the biological milieu. In "Biological Membranes: Structure, Biogenesis and Dynamics." J.A.F. Op den Kamp (Ed.). NATO ASI Series H: Cell Biology 82:101.
19. van Oss, C.J., Absolom, D.R., Neumann, A.W. and Lingg, W. 1981. Determination of the surface tension of proteins: surface tension of native serum proteins in aqueous media. Biochim. Biophys. Acta. 670:64.
20. Absolom, D.R., van Oss, C.J., Zingg, W. and Neumann, A.W. 1982. Phagocytosis as a surface phenomenon: opsonization by a specific adsorption of IgG as a function of bacteria hydrophobicity. J. Reticuloendothelial Soc. 31:59.
21. Semple, S.C., Chonn, A. and Cullis, P.R. 1995. Influence of cholesterol on the association of plasma proteins with liposomes, submitted.
22. Moghimi, S. M. and Patel, H. M. 1988. Tissue specific opsonins for phagocytic cells and their different affinity for cholesterol-rich liposomes. FEBS Lett. 233:143.
23. Moghimi, S. M. and Patel, H. M. 1989. Differential properties of organ-specific serum opsonins for liver and spleen macrophages. Biochim. Biophys. Acta 984:379.
24. Moghimi, S. M. and Patel, H. M. 1989. Serum opsonins and phagocytosis of saturated and unsaturated phopholipid liposomes. Biochim. Biophys. Acta 984:384.
25. Moghimi, S. M. and Patel, H. M. 1990. Calcium as a possible modulator of Kupffer cell phagocytic function by regulating liver-specific opsoninc activity. Biochim. Biophys. Acta 1028:304.
26. Chonn, A. and Cullis, P.R. 1992. Ganglioside GM1 and hydrophilic polymers increase liposome circulation times by inhibiting the association of blood proteins. J. Liposome Res. 2(3):397.
27. Wassef, N. and Alving, C.R. 1993. Complement-dependent phagocytosis of liposomes. Chem. Phys. Lipids 64:239.
28. Park, Y.S. and Huang, L. 1993. Effect of chemically modified GM1 and neoglycolipid analogs of GM1 on liposome circulation time: evidence supporting the dysopsonin hypothesis. Biochim. Biophys. Acta 1166:105.
29. Wassef, N.M., Matyas, G.R. and Alving, C.R. 1991. Complement-dependent phagocytosis of liposomes by macrophages: suppressive effects of "stealth lipids". Biochem. Biophys. Res. Comm. 176(2):866.
30. Klibanov, A.L., Maruyama, K., Torchilin, V.P. and Huang, L. 1990. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 268:235.
31. Allen, T.M., Hancen, C., Martin, F., Redemann, C. and Yau-Young, A. 1991. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta 1066:29.
32. Mori, A., Klibanov, A.L., Torchilin, V.P. and Huang, L. 1991. Influence of the steric barrier of amphipathic poly(ethylene glycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo. FEBS Lett. 284:263.
33. Maruyama, K., Yuda, T., Ishikura, C., Kojima, S. and Iwatsuru, M. 1991. Effect of molecular weight in amphipathic polyethyleneglycol on prolonging the circulation time of large unilamellar liposomes. Chem. Pharm. Bull. 39:1620.
34. Senior, J., Delgado, C., Fisher, D., Tilcock, C. and Gregoriadis, G. 1991. Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. Biochim. Biophys. Acta 1062:77.
35. Litzinger, D.C., Buiting, A.M.J., van Rooijen, N. and Huang, L. 1994. Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochim. Biophys. Acta 1190:99.
36. Aramaki, Y., Murai, M. and Tsuchiya, S. 1993. The contribution of a serum component(s) modified by B cells to the mechanism for macrophage activation by liposomes. Immunology 80:253.
37. Horbett, T.A. and Brash, J.L. 1987. "Proteins at Interfaces: Physicochemical and Biochemical Studies.", American Chemical Society, Washington, D.C.
38. Vroman, L. 1987. Methods of investigating protein interactions on artificial and natural surfaces. Ann. New York Acad. Sci. 516:300.
39. Chonn, A., Cullis, P.R. and Devine, D.V. 1991. The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes. J. Immunol. 146(12):4234.
40. Kiwada, H., Obara, S., Nishiwaki, H. and Kato, Y. 1986. Studies on the uptake mechanism of liposomes by perfused rat liver. I. An investigation of effluent profiles with perfusate containing no blood component. Chem. Pharm. Bull. 34:1249.
41. Kiwada, H., Miyajima, T. and Kato, Y. 1987. Studies on the uptake mechanism of liposomes by perfused rat liver. II. An indispensable factor for liver uptake in serum. Chem. Pharm. Bull. 35:1189.
42. Nishikawa, K., Arai, H. and Inoue, K. 1990. Scavenger receptor-mediated uptake and metabolism of lipid vesicles containing acidic phospholipids by mouse peritoneal macrophages. J. Biol. Chem. 265:5226.
43. Lee, K-D., Pitas, R.E. and Papahadjopoulos, D. 1992. Evidence that the scavenger receptor is not involved in the uptake of negatively charged liposomes by cells. Biochim. Biophys. Acta 1111:1.
44. Gregoriadis, G. 1988. Fate of injected liposomes: observations on entrapped solute retention, vesicle clearance and tissue distribution in vivo. In "Liposomes as drug carriers: recent trends and progress." G. Gregoriadis (Ed.). John Wiley and Sons Ltd., pg. 3.
45. Hwang, K. J. and Beaumier, P. L. 1988. Disposition of liposomes in vivo. In "Liposomes as Drug Carriers: Recent Trends and Progress." G. Gregoriadis, (Ed.). John Wiley and Sons Ltd., pg. 19.
46. Tall, A. R. and Green, P. H. R. 1981. Incorporation of phosphatidylcholine into spherical and discoidal lipoproteins during incubation of egg phosphatidylcholine vesicles with isolated high density lipoproteins or with plasma. J. Biol. Chem. 256:2035.
47. Chobanian, J. V., Tall, A. R. and Brecher, P. I. 1979. Interaction between unilamellar egg yolk lecithin vesicles and human high density lipoprotein. Biochemistry 18:180.
48. Scherphof, G., Roerdink, F., Waite, M. and Parks, J. 1978. Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipoproteins. Biochim. Biophys. Acta 542:296.
49. Krupp, L., Chobanian, A.V. and Brecher, P.I. 1976. The in vivo transformation of phospholipid vesicles to a particle resembling HDL in the rat. Biochem. Biophys. Res. Commun. 72(4):1251.
50. Tall, A.R. 1980. Studies on the transfer of phosphatidylcholine from unilamellar vesicles into plasma HDL in the rat. J. Lipid Res. 21:354.
51. Shahrokh, Z. and Nichols, A. V. 1982. Particle size interconversion of human low density lipoproteins during incubation of plasma with phosphatidylcholine vesicles. Biochem. Biophys. Res. Commun. 108:888.
52. Senior, J. and Gregoriadis, G. 1984. Role of lipoproteins instability and clearance of liposomes administered to mice. Bioc. Soc. Trans. 12(2):339.
53. Guo, L. S. S., Hamilton, R. L., Goerke, J., Weinstein, J. N. and Havel, R. J. 1980. Interaction of unilamellar liposomes with serum lipoproteins and apolipoproteins. J. Lipid Res. 21:993.
54. Atkinson, D., Smith, H. M., Dickinson, J. and Austin, J. P. 1976. Interaction of apoprotein from porcine high-density lipoprotein with dimyristoyl lecithin. I. The structure of the complexes. Eur. J. Biochem. 64:541.
55. Forte, T., Nichols, A. V., Gong, E. L., Lux, S. and Levy, R. I. 1971. Electron microscopic study on reassembly of plasma high density apoprotein with various lipids. Biochim. Biophys. Acta 248:381.
56. Swaney, J.B. 1980. Properties of lipid-apolipoprotein association products. Complexes of human apo A-I and binary phospholipid mixtures. J. Biol. Chem. 255(18):8798.
57. Swaney, J.B. 1980. Mechanisms of protein-lipid interaction. Association of apolipoproteins A-I and A-II with binary phospholipid mixtures. J. Biol. Chem. 255(18):8791.
58. Tall, A. 1986. Plasma lipid transfer proteins. J. Lipid Res. 27:361.
59. Tall, A. R., Abreu, E. and Shuman, J. 1983. Separation of a plasma phospholipid transfer protein from cholesterol ester/phospholipid exchange protein. J. Biol. Chem. 258:2174.
60. Tall, A. R., Forester, L. and Bongiovanni, G. 1983. Facilitation of phosphatidylcholine transfer into high density lipoproteins by an apolipoprotein in the density 1.20-1.26 g/ml fraction of plasma. J. Lipid Res. 24:277.
61. Muller-Eberhard, H. J. 1986. The membrane attack complex of complement. Annu. Rev. Immunol. 4:503.
62. Finkelstein, M. C. and Weissmann, G. 1979. Enzyme replacement via liposomes: Variations in lipid composition determine liposomal integrity in biological fluids. Biochim. Biophys. Acta 587:202.
63. Haxby, J. A., Gotze, O., Muller-Eberhard, H. J. and Kinsky, S. C. 1969. Release of trapped marker from liposomes by the action of purified complement components. Proc. Nat. Acad. Sci. USA 64:290.
64. Kinsky, S. C., Haxby, J. A., Zopf, D. A., Alving, C. R. and Kinsky, C. B. 1969. Complement-dependent damage to liposomes prepared from pure lipids and Forssman hapten. Biochemistry 8:4149.
65. Kataoka, T., Inoue, K., Luderitz, O. and Kinsky, S.C. 1971. Antibody- and complement-dependent damage to liposomes prepared with bacterial lipopolysaccharides. Eur. J. Biochem. 21(1):80.
66. Inoue, K., Kinoshita, T., Okada, M. and Akiyama, Y. 1977. Release of phospholipids from liposomal model membrane damaged by antibody and complement. J. Immunol. 119:73.
67. Shin, M. L., Paznekas, W. A. and Mayer, M. M. 1978. On the mechanism of membrane damage by complement: the effect of length and unsaturation of the acyl chains in liposomal bilayers and the effect of cholesterol concentration in sheep erythrocyte and liposomal membranes. J. Immunol. 120:1996.
68. Kinoshita, T., Inoue, K., Okada, M. and Akiyama, Y. 1977. Release of phospholipids from complement-mediated lesions on the surface structure of Escherichia coli. J. Immunol. 119:73.
69. Absolom, D.R. 1986. Opsonins and dysopsonins: an overview. Meth. Enzymol. 132:281.
70. Patel, H.M. 1992. Influence of lipid composition on opsonophagocytosis of liposomes. Res. Immunol. 143(2):242.
71. Patel, H.M. 1992. Serum opsonins and liposomes: their interaction and opsonophagocytosis. Crit. Rev. Ther. Drug Carrier Sys. 9(1):39.
72. Roerdink, F., Wassef, N. M., Richardson, E. C. and Alving, C. R. 1983. Effects of negatively charged lipids on phagocytosis of liposomes opsonized by complement. Biochim. Biophys. Acta 734:33.
73. Verma, J.N., Wassef, N.M., Wirtz, R.A., Atkinson, C.T., Aikawa, M., Loomis, L.D. and Alving, C.R. 1991. Phagocytosis of liposomes by macrophages: intracellular fate of malaria antigen. Biochim. Biophys. Acta 1066:229.
74. Devine, D.V., Wong, K. Serrano, K., Chonn, A. and Cullis, P.R. 1994. Liposome-complement interactions in rat serum: implications for liposome survival studies. Biochim. Biophys. Acta. 1191:43.
75. Marjan, J., Zongcen, X. and Devine, D.V. 1994. Liposome-induced activation of the classical complement pathway does not require immunoglobulin Biochim. Biophys. Acta 1192:35.
76. Thielens, N. M. and Colomb, M. G. 1986. A model for the study of the assembly and regulation of human complement C3 convertase (classical pathway). Eur. J. Immunol. 16:617.
77. Funato, K., Yoda, R. and Kiwada, H. 1991. Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in rat fresh plasma. Biochim. Biophys. Acta 1103:198.
78. Mold, C. 1989. Effect of membrane phospholipids on activation of the alternative complement pathway. J. Immunol. 143(5):1663.
79. Thiel, S. 1992. Mannan-binding protein, a complement activating animal lectin. Immunopharmacology 24(2):91.
80. Kuhlman, M., Joiner, K. and Ezekowitz, R.A. 1989. The human mannose-binding protein functions as an opsonin. J. Exp. Med. 169(5):1733.
81. Marjan, J. 1994. The interaction of liposomes with complement proteins and protein S. Ph.D. Thesis, The University of British Columbia.
82. Derksen, J. T. P., Morselt, H. W. M., Kalicharan, D., Hulstaert, C. E. and Scherphof, G. L. 1987. Interaction of immunoglobulin-coupled liposomes with rat liver macrophages in vitro. Exp. Cell Res. 168:105.
83. Hsu, M. J. and Juliano, R. L. 1982. Interactions of liposomes with the reticuloendothelial system. II. Nonspecific and receptor-mediated uptake of liposomes by mouse peritoneal macrophages. Biochim. Biophys. Acta 720:411.
84. Lewis, J. T., Hafeman, D. G. and McConnell, H. M. 1980. Kinetics of antibody-dependent binding of haptenated phospholipid vesicles to a macrophage-related cell line. Biochemistry 19:5376.
85. Leserman, L. D., Weinstein, J. N., Blumenthal, R. and Terry, W. D. 1980. Receptor-mediated endocytosis of antibody-opsonized liposomes by tumor cells. Proc. Natl. Acad. Sci. USA 77:4089.
86. Debs, R.J., Heath, T.D. and Papahadjopoulos, D. 1987. Targeting of anti-Thy 1.1 monoclonal antibody conjugated liposomes in Thy 1.1 mice after intravenous administration. Biochim. Biophys. Acta 901(2):183.
87. Torchilin, V.P., Klibanov, A.L., Huang, L., O'Donnell, S., Nossiff, N.D. and Khaw, B.A. 1992. Targeted accumulation of polyethylene glycol-coated immunoliposomes in infarcted rabbit myocardium. FASEB Journal 6(9):2716.
88. Cheng, H. M., Ngeow, Y. F. and Sam, C. K. 1989. Heat inactivation of serum potentiates anti-cardiolpin antibody binding in ELISA. J. Immunol. Methods 124:235.
89. Lechner, K and Pabinger-Fasching, I. 1987. Lupus anticoagulants and thrombosis. A study of 25 cases and review of the literature. Haemostasis 15(4):254.
90. Alving, C. R. 1984. Natural antibodies against phospholipids and liposomes in humans. Biochem. Soc. Trans. 12:342.
91. Shapiro, S. S. and Thiagarajan, P. 1982. Lupus anticoagulants. Prog. Hemostas. Thromb. 6:263.
92. Rauch, J., Tannenbaum, M., Tannenbaum, H., Ramelson, H., Cullis, P. R., Tilcock, C. P. S., Hope, M. J. and Janoff, A. S. 1986. Human hybridoma lupus anticoagulants distinguish between lamellar and hexagonal phase lipid systems. J. Biol. Chem. 261:9672.
93. Senior, J., Waters, J. A. and Gregoriadis, G. 1986. Antibody-coated liposomes: the role of non-specific antibody adsorption. FEBS Lett. 196:54.
94. Brown, E. J. 1986. The role of extracellular matrix proteins in the control of phagocytosis. J. Leukoc. Biol. 39:579.
95. Ruoslahti, E. 1988. Fibronectin and its receptors. Ann. Rev. Biochem. 57:375.
96. Pommier, C. G., Inada, I., Fries, L. F., Takahashi, T., Frank, M. M. and Brown, E. J. 1983. Plasma fibronectin enhances phagocytosis of opsonized particles by human peripheral blood monocytes. J. Exp. Med. 157:1844.
97. Williams, K. J. and Scanu, A. M. 1986. Uptake of endogenous cholesterol by a synthetic lipoprotein. Biochim. Biophys. Acta 875:183.
98. Ivanov, V. O., Preobrazhensky, S. N., Tsibulsky, V. P., Babaev, V. R., Repin, V. S. and Smirnov, V. N. 1985. Liposome uptake by cultured macrophages mediated by modified low-density lipoproteins. Biochim. Biophys. Acta 846:76.
99. Williams, K. J., Tall, A. R., Bisgaier, C. and Brocia, R. 1987. Phospholipid liposomes acquire apolipoprotein E in atherogenic plasma and block cholesterol loading of cultured macrophages. J. Clin. Invest. 79:1466.
100. Williams, K. J., Werth, V. P. and Wolff, J. A. 1984. Intravenously administered lecithin liposomes: a synthetic antiatherogenic lipid particle. Perspect. Biol. Med. 27:417.
101. Bisgaier, C. L., Siebenkas, M. V. and Williams, K.J. 1989. Effects of apolipoproteins A-IV and A-I on the uptake of phospholipid liposomes by hepatocytes. J. Biol. Chem. 264:862.
102. Young, B., Gleeson, M. and Cripps, A.W. 1991. C-reactive protein: a critical review. Pathology 23:118.
103. Steel, D.M. and Whitehead, A.S. 1994. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol. Today 15(2):81.
104. Volanakis, J. E. and Kaplan, M. H.. 1974. Interactions of C-reactive protein with the complement system. II. Consumption of guinea pig complement by CRP complexes: requirement for human C1q. J. Immunol. 113:9.
105. Kaplan, M. H. and Volanakis, J. E. 1974. Interactions of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin, and sphingomyelin. J. Immunol. 112:2135.
106. Siegel, J., Rent, R. and Gewurz, G. 1974. Interactions of C-reactive protein with the complement system. I. Protamine-induced consumption of complement in acute phase sera. J. Exp. Med. 140:631.
107. Siegel, J., Osmand, A. P., Wilson, M. F. and Gewurz, H. 1975. Interactions of C-reactive protein with the complement system. II. C-reactive protein-mediated consumption of complement by poly-L-lysine polymers and other polycations. J. Exp. Med. 142:709.
108. Osmand, A. P., Mortensen, R. F., Siegel, J. and Gewurz, H. 1975. Interactions of C-reactive protein with the complement system. III. Complement-dependent passive hemolysis initiated by CRP. J. Exp. Med. 142:1065.
109. Richards, R. L., Gewurz, H., Osmand, A. P. and Alving, C. R. 1977. Interactions of C-reactive protein and complement with liposomes. Proc. Natl. Acad. Sci. USA 74:5672.
110. Volanakis, J. E. and Narkates, A. J. 1981. Interaction of C-reactive protein with artificial phosphatidylcholine bilayers and complement. J. Immunol. 126:1820.
111. Barna, B. P., Deodhar, S. D., Gautam, S. Yen-Lieberman, B. and Roberts, D. 1984. Macrophage activation and generation of tumoricidal activity by liposome-associated human C-reactive protein. Cancer Res. 44:305.
112. Chonn, A., Semple, S.C. and Cullis, P.R. 1995. β2-glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a major role in the immune clearance of "nonself" particles. submitted.
113. Moghimi, S.M., Muir, I.S., Illum, L., Davis, S.S. and Kolb-Bachofen, V. 1993. Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. Biochim. Biophys. Acta 1179:157.